Research Insight

Immuneering Corporation announced today that it has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb for the use of Immuneering’s proprietary computational biology methods to identify biological insights that may facilitate discovery...

The Innovative Medicines Initiative (IMI) is calling experts to join forces and tackle two challenges which are of major importance to public health. Measuring the combined benefits and risks of vaccines and assessing the effectiveness of...

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association's...

A new class of nanoparticles, synthesized by a UC Davis research team to prevent premature drug release, holds promise for greater accuracy and effectiveness in delivering cancer drugs to tumors. The work is published in the current issue...

Mylan Institutional business has launched Levetiracetam in Sodium Chloride Injection of multiple strengths, 500mg/100ml, 1000mg/100ml and 1500mg/100ml, for intravenous use. Levetiracetam in sodium chloride injection is an antiepileptic drug indicated for adults with different...

Vidacare's study to compare Intraosseous (IO) vascular access to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia showed no statistical difference between the two routes.   The study was named...

Bayer HealthCare announced that researchers have presented data from two international long-term follow-up studies in multiple sclerosis: the BENEFIT (BEtaferon in Newly Emerging multiple sclerosis For Initial Treatment) 8-Year Extension Study and the Betaferon® 21-Year Long-term Follow-up (LTF) Study....